{"id":50045,"date":"2022-10-25T16:01:53","date_gmt":"2022-10-25T14:01:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/"},"modified":"2022-10-25T16:01:53","modified_gmt":"2022-10-25T14:01:53","slug":"iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/","title":{"rendered":"Iron Bow Technologies Selected to Support VA\u2019s $650M Accelerating VA Innovation and Learning Program"},"content":{"rendered":"<div>\n<p>HERNDON, Va.&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/IT?src=hash\" target=\"_blank\" rel=\"noopener\">#IT<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fironbow.com%2F&amp;esheet=52951303&amp;newsitemid=20221025005128&amp;lan=en-US&amp;anchor=Iron+Bow+Technologies&amp;index=1&amp;md5=21c4519eb8a88d1b8bc449951f95d39a\" rel=\"nofollow noopener\" shape=\"rect\">Iron Bow Technologies<\/a>, the leading technology solutions provider to government, healthcare and commercial markets, has been awarded a five-year contract from the Department of Veterans Affairs (VA) to deliver transformative healthcare solutions that advance VHA\u2019s mission of providing world-class care to our nation\u2019s Veterans.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221025005128\/en\/271968\/5\/ironbow_color_tag_medium.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221025005128\/en\/271968\/21\/ironbow_color_tag_medium.jpg\"><\/a><\/p>\n<p>\nThe Accelerating VA Innovation and Learning (AVAIL) contract, with a value of $650M, was released under the Department of Veterans Affairs\u2019 Office of Healthcare Innovation and Learning (OHIL). The program will focus on innovative prototypes in precision medicine, advanced manufacturing, digital care solutions, immersive and extended reality solutions, and AI\/ML that will continue to transform the way care is delivered and received.\n<\/p>\n<p>\nIron Bow Healthcare Solutions attributes its demonstrated success developing and integrating emerging technologies in VA for over 12 years as one of the reasons for selection under the AVAIL program.\n<\/p>\n<p>\n\u201cWe are eager to expand our support of VA\u2019s mission through thoughtful innovation,\u201d said Angie Stevens, Chief Strategy Officer of Iron Bow Healthcare Solutions. \u201cLike VA, we believe true innovation in healthcare results in scalable delivery models with measurable improvements in cost, quality and provider and veteran satisfaction.\u201d\n<\/p>\n<p>\nIron Bow\u2019s AVAIL program team includes an esteemed advisory board with health and technology leadership across the public and private sector and a team of small and large business partners who collectively bring deep expertise across all facets of healthcare delivery. Their \u2018Veteran First\u2019 mantra will help lead this team to success.\n<\/p>\n<p>\n<b>About Iron Bow Healthcare Solutions<\/b>\n<\/p>\n<p>\nIron Bow Healthcare Solutions is at the forefront of digital health transformation and continues to develop, implement, manage, manufacture, and support solutions across the care continuum. Our extensive industry and clinical workflow knowledge combined with technology expertise empower clients to deliver enhanced patient outcomes. We partner closely with our clients from consulting to implementation so they can provide patients with better access to care. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ironbowhealthcare.com%2F&amp;esheet=52951303&amp;newsitemid=20221025005128&amp;lan=en-US&amp;anchor=www.ironbowhealthcare.com.&amp;index=2&amp;md5=840ed5f4bff4a5867c3434e06549451a\" rel=\"nofollow noopener\" shape=\"rect\">www.ironbowhealthcare.com.<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media:<\/b><br \/>Kate Nesbitt<br \/>\n<br \/>Alloy Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x6b;&#97;&#x74;&#101;&#x40;&#104;&#x65;&#108;&#x6c;&#111;&#x61;&#108;&#x6c;&#111;&#x79;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\"><b>&#107;&#x61;&#116;&#x65;&#64;&#x68;e&#108;&#x6c;&#111;&#x61;l&#x6c;o&#121;&#x2e;&#99;&#x6f;m<\/b><\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>HERNDON, Va.&#8211;(BUSINESS WIRE)&#8211;#IT&#8212;Iron Bow Technologies, the leading technology solutions provider to government, healthcare and commercial markets, has been awarded a five-year contract from the Department of Veterans Affairs (VA) to deliver transformative healthcare solutions that advance VHA\u2019s mission of providing world-class care to our nation\u2019s Veterans. The Accelerating VA Innovation and Learning (AVAIL) contract, with &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50045","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Iron Bow Technologies Selected to Support VA\u2019s $650M Accelerating VA Innovation and Learning Program - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Iron Bow Technologies Selected to Support VA\u2019s $650M Accelerating VA Innovation and Learning Program - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"HERNDON, Va.&#8211;(BUSINESS WIRE)&#8211;#IT&#8212;Iron Bow Technologies, the leading technology solutions provider to government, healthcare and commercial markets, has been awarded a five-year contract from the Department of Veterans Affairs (VA) to deliver transformative healthcare solutions that advance VHA\u2019s mission of providing world-class care to our nation\u2019s Veterans. The Accelerating VA Innovation and Learning (AVAIL) contract, with ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-25T14:01:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221025005128\/en\/271968\/21\/ironbow_color_tag_medium.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Iron Bow Technologies Selected to Support VA\u2019s $650M Accelerating VA Innovation and Learning Program\",\"datePublished\":\"2022-10-25T14:01:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/\"},\"wordCount\":347,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025005128\\\/en\\\/271968\\\/21\\\/ironbow_color_tag_medium.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/\",\"name\":\"Iron Bow Technologies Selected to Support VA\u2019s $650M Accelerating VA Innovation and Learning Program - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025005128\\\/en\\\/271968\\\/21\\\/ironbow_color_tag_medium.jpg\",\"datePublished\":\"2022-10-25T14:01:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025005128\\\/en\\\/271968\\\/21\\\/ironbow_color_tag_medium.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025005128\\\/en\\\/271968\\\/21\\\/ironbow_color_tag_medium.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Iron Bow Technologies Selected to Support VA\u2019s $650M Accelerating VA Innovation and Learning Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Iron Bow Technologies Selected to Support VA\u2019s $650M Accelerating VA Innovation and Learning Program - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/","og_locale":"en_US","og_type":"article","og_title":"Iron Bow Technologies Selected to Support VA\u2019s $650M Accelerating VA Innovation and Learning Program - Pharma Trend","og_description":"HERNDON, Va.&#8211;(BUSINESS WIRE)&#8211;#IT&#8212;Iron Bow Technologies, the leading technology solutions provider to government, healthcare and commercial markets, has been awarded a five-year contract from the Department of Veterans Affairs (VA) to deliver transformative healthcare solutions that advance VHA\u2019s mission of providing world-class care to our nation\u2019s Veterans. The Accelerating VA Innovation and Learning (AVAIL) contract, with ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-25T14:01:53+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221025005128\/en\/271968\/21\/ironbow_color_tag_medium.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Iron Bow Technologies Selected to Support VA\u2019s $650M Accelerating VA Innovation and Learning Program","datePublished":"2022-10-25T14:01:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/"},"wordCount":347,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221025005128\/en\/271968\/21\/ironbow_color_tag_medium.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/","url":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/","name":"Iron Bow Technologies Selected to Support VA\u2019s $650M Accelerating VA Innovation and Learning Program - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221025005128\/en\/271968\/21\/ironbow_color_tag_medium.jpg","datePublished":"2022-10-25T14:01:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221025005128\/en\/271968\/21\/ironbow_color_tag_medium.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221025005128\/en\/271968\/21\/ironbow_color_tag_medium.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/iron-bow-technologies-selected-to-support-vas-650m-accelerating-va-innovation-and-learning-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Iron Bow Technologies Selected to Support VA\u2019s $650M Accelerating VA Innovation and Learning Program"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50045"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50045\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50045"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50045"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}